You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

ANCEF Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Ancef patents expire, and when can generic versions of Ancef launch?

Ancef is a drug marketed by Glaxosmithkline and Baxter Hlthcare and is included in three NDAs.

The generic ingredient in ANCEF is cefazolin sodium. There are twenty-seven drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the cefazolin sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Ancef

A generic version of ANCEF was approved as cefazolin sodium by SANDOZ on December 9th, 1988.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ANCEF?
  • What are the global sales for ANCEF?
  • What is Average Wholesale Price for ANCEF?
Summary for ANCEF
US Patents:0
Applicants:2
NDAs:3
Raw Ingredient (Bulk) Api Vendors: 64
Patent Applications: 2,824
DailyMed Link:ANCEF at DailyMed
Drug patent expirations by year for ANCEF

US Patents and Regulatory Information for ANCEF

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline ANCEF cefazolin sodium INJECTABLE;INJECTION 050461-003 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Baxter Hlthcare ANCEF IN DEXTROSE 5% IN PLASTIC CONTAINER cefazolin sodium INJECTABLE;INJECTION 050566-004 Jun 8, 1983 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Glaxosmithkline ANCEF cefazolin sodium INJECTABLE;INJECTION 050461-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Baxter Hlthcare ANCEF IN PLASTIC CONTAINER cefazolin sodium INJECTABLE;INJECTION 063002-001 Mar 28, 1991 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Glaxosmithkline ANCEF cefazolin sodium INJECTABLE;INJECTION 050461-004 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Glaxosmithkline ANCEF cefazolin sodium INJECTABLE;INJECTION 050461-005 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.